Navigation Links
Ophthalmic Consultants of Long Island (OCLI), the Largest and One of the Most Prestigious Multi-Specialty Ophthalmology Practices on Long Island, Participates in Mission Cataract USA
Date:7/20/2009

WESTBURY, N.Y., July 20 /PRNewswire/ -- Throughout August and September, doctors in the Ophthalmic Consultants of Long Island (OCLI) practice will perform FREE surgery at the Island Eye Surgicenter to give the gift of sight to those who have lost some or all of their vision because of cataracts. OCLI, a participant in the Mission Cataract USA program, is offering this outpatient surgical procedure to residents of Nassau, Suffolk and Queens who are not covered by medical insurance and who are unable to pay for the surgery themselves. For more information, please visit www.ocli.net.

"OCLI has a history of giving back to the community, through the personal efforts of our eye care doctors and as a group. This effort is one more piece of our OCLI 'Renewed Vision(TM)' program and it is an innovative way to give back to the community we serve" said Tom Burke, CEO of OCLI. He continued, "We participate in similar projects, such as Healthy Vision 2010 with The National Eye Institute and Eye Care America with the American Academy of Ophthalmology. These efforts help us reach vision and service objectives as part of a shared responsibility for national disease prevention that helps to improve the health of all Americans."

OCLI has performed charitable surgical procedures for many years with various local service organizations including The Lion's Eye Bank and The Sons of Italy. For this Mission Cataract effort, the doctors, technicians and nurses volunteer their services free of charge. The procedures will be performed at the Island Eye Surgicenter, in Carle Place.

Participating cataract surgeons include: Stanley Berke, MD, Robert Broderick, MD, Ronald Caronia, MD, Gerard D'Aversa, MD, Eric Donnenfeld, MD, Russell Fumuso, MD, David Nelson, MD, David Sachs, MD and Richard Sturm, MD.

Those who meet Mission Cataract guidelines and want more information should visit www.ocli.net or call: 1-866-SEE-OCLI (1-866-733-6254) before July 31(st).

The following corporate and individual professionals along with their staff, have generously contributed professional services, surgical supplies, pharmaceuticals and equipment to bring this community service to reality: Julie Suarez, M.D. Rockville Centre, Roman P. Urbanczck, M.D. Valley Stream (Rotacare), Brad Litwak, MD and Nassau Ambulatory Anesthesia Associates, Abbott Medical Optics, Allergan, Bausch and Lomb, Cardinal Health Incorporated and Integrated Medical Supplies.

Mission Cataract began in 1991 and since then, hundreds of people throughout the United States have undergone the procedure to remove their cataracts at no cost to them.

Cataracts are very common. Approximately 20.5 million Americans age 40 and older have cataracts. New advances and techniques have made cataract surgery one of the most successful and life-improving surgical procedures. Cataract surgery is usually done as an outpatient procedure under local anesthesia. In this procedure, the eye surgeon makes a tiny incision through which he or she removes the cloudy lens and replaces it with a permanent artificial lens. It can have an enormous impact on the quality of someone's life. Cataract surgery is usually covered by medical insurance, including Medicare.

About Ophthalmic Consultants of Long Island

OCLI, one of the largest ophthalmology practices in the nation, consists of 21 eye specialists representing each subspecialty of ophthalmology in 6 locations throughout Long Island; in Rockville Centre, Lynbrook, Valley Stream, Stony Brook, Manhasset and East Meadow. OCLI also has a research department that is involved in FDA studies to improve the treatment and diagnosing of ophthalmic diseases.

For more information, please call 1-866-SEE-OCLI (1-866-733-6254) or visit www.ocli.net.

About Island Eye Surgicenter

Island Eye Surgicenter is a New York State licensed and Medicare certified Ambulatory Surgery Center and has been nationally accredited by AAAHC (the Accreditation Association for Ambulatory Health Care). Island Eye Surgicenter is unique in that it specializes in the surgical care and treatment of eye disorders. The center has made significant contributions in its pharmaceutical and device research activities. Island Eye Surgicenter is also a N.Y. State licensed Tissue Transplantation facility, and is a leader in the field of Corneal Transplantation. www.islandeye.net.

    Media Contact:
    Deanna Morton, InfiniTech Public Relations
    516.829.5502
    dmorton@infinitechpronline.com


'/>"/>
SOURCE Ophthalmic Consultants of Long Island
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
2. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
3. Endure Medical Redefines Ophthalmic Surgical Microscopes
4. VIDEO from Medialink and Pfizer Ophthalmics: On World Glaucoma Day, Keep an Eye on the Future
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. AUDIO from Medialink and Pfizer Ophthalmics: Glaucoma - The Sneak Thief of Sight
7. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
8. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
9. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
10. The danger of blindness after ophthalmic surgery
11. Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: